Related News
Drug companies involved in bribery and tax evasion
By Jane Chen |
August 21, 2009, Friday
|
Online Edition
Online Edition
A PARMACEUTICAL industry insider has called on the government to crack down on the industry, which he says is rife with bribery, money laundering and tax evasion, resulting in higher costs of medicines.
Lu Tao, who has worked 10 years in the industry, with four as a drug sales representative, disclosed it in today's China Youth Daily.
Under Chiona's rules governing drug sales, companies must tell the drug authority the cost of making the drugs before supplying them to hospitals and other businesses. Hospitals then sell them to patients for no more than 15 percent more than their supply prices.
But in practice, drug companies quote much higher costs to make more profit, Lu said.
Lu cited an unnamed drug as an example, saying it cost 26 yuan (US$3.80) a bottle to produce but told the authority it cost 189 yuan.
To get hospitals to use their drugs, sales representatives usually bribe hospital staff, from the principal to the frontline doctors, Lu added.
It has become normal practice for sales people to give money equivalent to 20-35 percent of the drug prices to doctors to encourage them to use their products, he disclosed.
Hospitals would suspend buying a drug if it is not prescribed for three months, according to the drug management rule. To make a suspended drug re-enter a hospital is nearly impossible, he explained.
The industry is also involved in tax evasion, Lu claimed.
Some companies sell drugs to a third party at higher prices before forwarding them to hospitals to get higher tax rebates, he said.
Lu Tao, who has worked 10 years in the industry, with four as a drug sales representative, disclosed it in today's China Youth Daily.
Under Chiona's rules governing drug sales, companies must tell the drug authority the cost of making the drugs before supplying them to hospitals and other businesses. Hospitals then sell them to patients for no more than 15 percent more than their supply prices.
But in practice, drug companies quote much higher costs to make more profit, Lu said.
Lu cited an unnamed drug as an example, saying it cost 26 yuan (US$3.80) a bottle to produce but told the authority it cost 189 yuan.
To get hospitals to use their drugs, sales representatives usually bribe hospital staff, from the principal to the frontline doctors, Lu added.
It has become normal practice for sales people to give money equivalent to 20-35 percent of the drug prices to doctors to encourage them to use their products, he disclosed.
Hospitals would suspend buying a drug if it is not prescribed for three months, according to the drug management rule. To make a suspended drug re-enter a hospital is nearly impossible, he explained.
The industry is also involved in tax evasion, Lu claimed.
Some companies sell drugs to a third party at higher prices before forwarding them to hospitals to get higher tax rebates, he said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
